Identifying antibiotic-resistant bacteria in hospitalized patients: what is the role of active-surveillance cultures?

PubWeight™: 0.75‹?›

🔗 View Article (PMID 23616638)

Published in Clin Chem on April 24, 2013

Authors

Thomas J Sandora1, Susan A Dolan, Stephan Harbarth, Susan S Huang, Alexander J McAdam, Aaron M Milstone

Author Affiliations

1: Division of Infectious Diseases, Departments of Medicine and Laboratory Medicine, Boston Children's Hospital, Boston, MA;

Articles by these authors

The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86

Parallel bacterial evolution within multiple patients identifies candidate pathogenicity genes. Nat Genet (2011) 4.81

Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med (2006) 4.15

Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J (2007) 3.99

Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Infect Control Hosp Epidemiol (2007) 3.57

Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2005) 3.18

Ready for a world without antibiotics? The Pensières Antibiotic Resistance Call to Action. Antimicrob Resist Infect Control (2012) 3.02

Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med (2007) 2.88

Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis (2008) 2.79

Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51

Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis (2009) 2.39

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35

Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35

Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med (2004) 2.33

The potential regional impact of contact precaution use in nursing homes to control methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2012) 2.22

A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis (2004) 2.22

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis (2007) 2.11

Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis (2006) 1.99

Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2007) 1.97

Catheter duration and risk of CLA-BSI in neonates with PICCs. Pediatrics (2010) 1.88

A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med (2011) 1.88

Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol (2005) 1.88

Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol (2008) 1.78

Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis (2008) 1.77

Reporting surgical site infections following total hip and knee arthroplasty: impact of limiting surveillance to the operative hospital. Clin Infect Dis (2013) 1.75

Recommendations for metrics for multidrug-resistant organisms in healthcare settings: SHEA/HICPAC Position paper . Infect Control Hosp Epidemiol (2008) 1.73

Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics (2010) 1.72

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70

Validation of syndromic surveillance for respiratory infections. Ann Emerg Med (2006) 1.65

A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol (2004) 1.63

Inclusion of 30-day postdischarge detection triples the incidence of hospital-onset methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2011) 1.63

Impact of combined low-level mupirocin and genotypic chlorhexidine resistance on persistent methicillin-resistant Staphylococcus aureus carriage after decolonization therapy: a case-control study. Clin Infect Dis (2011) 1.62

Temporal effects of antibiotic use and hand rub consumption on the incidence of MRSA and Clostridium difficile. J Antimicrob Chemother (2008) 1.60

Quantifying uncertainty: physicians' estimates of infection in critically ill neonates and children. Clin Infect Dis (2004) 1.57

Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics (2008) 1.55

Knowledge, awareness, and attitudes regarding methicillin-resistant Staphylococcus aureus among caregivers of hospitalized children. J Pediatr (2010) 1.54

Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? Infect Control Hosp Epidemiol (2011) 1.52

Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence. J Clin Microbiol (2007) 1.51

Silencing of host cell CYBB gene expression by the nuclear effector AnkA of the intracellular pathogen Anaplasma phagocytophilum. Infect Immun (2009) 1.51

Is throat screening necessary to detect methicillin-resistant Staphylococcus aureus colonization in patients upon admission to an intensive care unit? J Clin Microbiol (2007) 1.51

Prospective multicenter study of the viral etiology of bronchiolitis in the emergency department. Acad Emerg Med (2008) 1.50

Methicillin-resistant Staphylococcus aureus burden in nursing homes associated with environmental contamination of common areas. J Am Geriatr Soc (2012) 1.50

Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance. Clin Infect Dis (2013) 1.50

Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis (2011) 1.50

Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: an observational study. Crit Care (2005) 1.49

Impact of Burkholderia dolosa on lung function and survival in cystic fibrosis. Am J Respir Crit Care Med (2005) 1.45

Staphylococcal enterotoxin P predicts bacteremia in hospitalized patients colonized with methicillin-resistant Staphylococcus aureus. J Infect Dis (2013) 1.43

Pneumococcal carriage and antibiotic resistance in young children before 13-valent conjugate vaccine. Pediatr Infect Dis J (2012) 1.41

Photo quiz: an 11-year-old with abdominal pain. J Clin Microbiol (2012) 1.39

Diversity of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from inpatients of 30 hospitals in Orange County, California. PLoS One (2013) 1.37

Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine (2010) 1.37

Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics (2003) 1.37

Quantifying the impact of extranasal testing of body sites for methicillin-resistant Staphylococcus aureus colonization at the time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol (2012) 1.36

Central line-associated bloodstream infection in hospitalized children with peripherally inserted central venous catheters: extending risk analyses outside the intensive care unit. Clin Infect Dis (2011) 1.36

Legislative mandates for use of active surveillance cultures to screen for methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: Position statement from the Joint SHEA and APIC Task Force. Am J Infect Control (2007) 1.33

Resistance of group B streptococcus to selected antibiotics, including erythromycin and clindamycin. J Clin Microbiol (2004) 1.33

Aging population and future burden of pneumococcal pneumonia in the United States. J Infect Dis (2012) 1.29

Carried pneumococci in Massachusetts children: the contribution of clonal expansion and serotype switching. Pediatr Infect Dis J (2011) 1.28

Increased use of second-generation macrolide antibiotics for children in nine health plans in the United States. Pediatrics (2004) 1.28

Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants. Arch Intern Med (2011) 1.27

Should this event be notified to the World Health Organization? Reliability of the international health regulations notification assessment process. Bull World Health Organ (2011) 1.27

Prevalence and prediction of previously unknown MRSA carriage on admission to a geriatric hospital. Age Ageing (2005) 1.27

Social network analysis of patient sharing among hospitals in Orange County, California. Am J Public Health (2011) 1.25

Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol (2014) 1.24

The importance of nursing homes in the spread of methicillin-resistant Staphylococcus aureus (MRSA) among hospitals. Med Care (2013) 1.23

Quasiexperimental study of the effects of antibiotic use, gastric acid-suppressive agents, and infection control practices on the incidence of Clostridium difficile-associated diarrhea in hospitalized patients. Antimicrob Agents Chemother (2009) 1.22

Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California. Infect Control Hosp Epidemiol (2010) 1.22

Methicillin-resistant Staphylococcus aureus, Geneva, Switzerland, 1993-2005. Emerg Infect Dis (2008) 1.21

Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? Clin Infect Dis (2009) 1.19

Detecting respiratory viruses in asymptomatic children. Pediatr Infect Dis J (2012) 1.19

High prevalence of reduced chlorhexidine susceptibility in organisms causing central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2014) 1.18

Public reporting of health care-associated surveillance data: recommendations from the healthcare infection control practices advisory committee. Ann Intern Med (2013) 1.16

Modeling the spread of methicillin-resistant Staphylococcus aureus (MRSA) outbreaks throughout the hospitals in Orange County, California. Infect Control Hosp Epidemiol (2011) 1.16

A systematic literature review and meta-analysis of factors associated with methicillin-resistant Staphylococcus aureus colonization at time of hospital or intensive care unit admission. Infect Control Hosp Epidemiol (2013) 1.16

The environment and healthcare-acquired infections: why accurate reporting and evaluation of biological plausibility are important. Infect Control Hosp Epidemiol (2013) 1.15

Cost implications of successful hand hygiene promotion. Infect Control Hosp Epidemiol (2004) 1.15

Methicillin-resistant Staphylococcus aureus transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization: challenges for infection prevention. Infect Control Hosp Epidemiol (2014) 1.14

Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat (2011) 1.14

Time-dependent study entries and exposures in cohort studies can easily be sources of different and avoidable types of bias. J Clin Epidemiol (2012) 1.13

Re-emergence of the type 1 pilus among Streptococcus pneumoniae isolates in Massachusetts, USA. Vaccine (2010) 1.12

Diversity of methicillin-resistant Staphylococcus aureus strains isolated from residents of 26 nursing homes in Orange County, California. J Clin Microbiol (2013) 1.12

Epidemiology and risk factors for Staphylococcus aureus colonization in children in the post-PCV7 era. BMC Infect Dis (2009) 1.11

Comparison of strategies to reduce meticillin-resistant Staphylococcus aureus rates in surgical patients: a controlled multicentre intervention trial. BMJ Open (2013) 1.11

Modelling the impact of antibiotic use on antibiotic-resistant Escherichia coli using population-based data from a large hospital and its surrounding community. J Antimicrob Chemother (2011) 1.10

An outbreak of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit. Infect Control Hosp Epidemiol (2012) 1.10

Cutting edge: inducible costimulator protein regulates both Th1 and Th2 responses to cutaneous leishmaniasis. J Immunol (2002) 1.10

Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control (2012) 1.10

Use of Medicare diagnosis and procedure codes to improve detection of surgical site infections following hip arthroplasty, knee arthroplasty, and vascular surgery. Infect Control Hosp Epidemiol (2011) 1.09

Bench-to-bedside review: Rapid molecular diagnostics for bloodstream infection--a new frontier? Crit Care (2012) 1.08

Epidemiology of methicillin-resistant Staphylococcus aureus: results of a nation-wide survey in Switzerland. Swiss Med Wkly (2002) 1.08

Risk factors for peripherally inserted central venous catheter complications in children. JAMA Pediatr (2013) 1.07

Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden. Infect Control Hosp Epidemiol (2011) 1.07

Swine-origin influenza a (H1N1) viral infection in children: initial chest radiographic findings. Radiology (2009) 1.07

Implementation of a central line maintenance care bundle in hospitalized pediatric oncology patients. Pediatrics (2012) 1.07

Chlorhexidine bathing in a tertiary care neonatal intensive care unit: impact on central line-associated bloodstream infections. Infect Control Hosp Epidemiol (2013) 1.06

Chlorhexidine and mupirocin susceptibilities of methicillin-resistant staphylococcus aureus from colonized nursing home residents. Antimicrob Agents Chemother (2012) 1.06